Drogues, sexe et risques dans la communauté gaie montréalaise : 1997-2003

Cet article décrit l’évolution de la consommation de drogues entre 1997 et 2003 chez des hommes gais et bisexuels séronégatifs de la grande région montréalaise, selon l’âge et selon les comportements sexuels à risque pour le VIH. Les données proviennent d’Oméga, une étude longitudinale sur l’incidence et les déterminants psychosociaux de l’infection au VIH chez ces hommes. Les participants ont rempli un questionnaire tous les six mois, et les données sont celles de leur première visite de suivi. Des analyses de tendance par période de calendrier ont été réalisées et un modèle de régression logistique utilisant une estimation par équations généralisées a été généré pour chaque type de drogues. Les résultats révèlent une augmentation de la consommation de cocaïne, de l’ecstasy, des hallucinogènes, du speed et du GHB entre 1997 et 2003. En revanche, la consommation de marijuana, de poppers et d’héroïne ne semble pas avoir changé de façon significative. Les moins de 30 ans et ceux qui ont eu des relations anales à risque semblent avoir été plus enclins à consommer certaines drogues pendant cette même période. Indices de transformations possibles dans les modes de vie de ces hommes, ces résultats soulèvent de nouveaux défis pour la prévention du VIH dans la communauté gaie.This article describes the evolution of drug use between 1997 and 2003 in HIV-negative men who have sex with men living in the Montreal region, according to age and HIV risk-taking behaviours. Data come from Omega, a longitudinal study on the incidence and on the psychosocial determinants of HIV infection among these men. Participants completed a questionnaire every six months and data are from the first follow-up visit. Trends analyses by calendar period were done and a logistic regression model using generalised equations for parameter estimation was generated for each type of drug. Results reveal an increase in cocaine, ecstasy, hallucinogen, speed and GHB use between 1997 and 2003. On the other hand, marijuana, poppers and heroin use do not seem to have change significantly. Men who are younger than 30 years old and who had risky anal intercourse seem to be more likely to have used specific drugs in the same period. This indicates possible transformations in the way of life of these men and these results suggest new challenges for HIV prevention in the gay community.Este artículo describe la evolución del consumo de drogas entre 1997 y 2003 entre los hombres gay y bisexuales seronegativos de la gran región montrealesa, según la edad y los comportamientos sexuales de riesgo con respecto al VIH. Los datos provienen de Oméga, un estudio longitudinal sobre la incidencia y los determinantes psicosociales de la infección de VIH en los hombres. Los participantes respondieron un cuestionario cada seis meses y los datos son los de su primera visita de seguimiento. Se realizaron análisis de tendencia por período de calendario y se generó un modelo de regresión logística, utilizando una estimación por ecuaciones generalizadas para cada tipo de droga. Los resultados revelan un aumento del consumo de cocaína, éxtasis, alucinógenos, speed y GHB entre 1997 y 2003. Por el contrario, el consumo de marihuana, poppers y heroína no parece haber cambiado de manera significativa. Los menores de 30 años y quienes tienen relaciones sexuales anales a riesgo parecen haber tenido una mayor tendencia a consumir ciertas drogas durante este mismo período. Estos resultados, índices de transformaciones posibles en los modos de vida de estos hombres, plantean nuevos desafíos en la prevención del VIH en la comunidad gay

HIV infection and sexual risk among men who have sex with men and women (MSMW): A systematic review and meta-analysis

Objectives: To estimate the number of men who have sex with men and women who are HIV-positive in the United States, and to compare HIV prevalence rates between men who have sex with men and women, men who have sex with men only, and men who have sex with women exclusively. Methods: Following PRISMA guidelines, we conducted a systematic review and meta-analysis of reports referencing HIV prevalence and men who have sex with men and women. We searched PubMed and Ovid PsycINFO for peer-reviewed, U.S.-based articles reporting on HIV prevalence among men who have sex with men and women. We conducted event rate, effect size, moderation and sensitivity analyses. Results: We estimate that 1.0% of U.S. males are bisexually-behaving, and that 121,800 bisexually-behaving men are HIV-positive. Men who have sex with men and women are less than half as likely to be HIV-positive as men who have sex with men only (16.9% vs. 33.3%; OR = 0.41, 95% CI: 0.31, 0.54), but more than five times as likely to be HIV-positive as men who have sex with women exclusively (18.3% vs. 3.5%; OR = 5.71, 95% CI: 3.47, 9.39). They are less likely to engage in unprotected receptive anal intercourse than men who have sex with men only (15.9% vs. 35.0%; OR = 0.36, 95% CI: 0.28, 0.46). Men who have sex with men and women in samples with high racial/ethnic minority proportions had significantly higher HIV prevalence than their counterparts in low racial/ethnic minority samples. Conclusions: This represents the first meta-analysis of HIV prevalence in the U.S. between men who have sex with men and women and men who have sex with men only. Data collection, research, and HIV prevention and care delivery specifically tailored to men who have sex with men and women are necessary to better quantify and ameliorate this population's HIV burden. © 2014 Friedman et al

Lack of Evidence of Sexual Transmission of Hepatitis C Virus in a Prospective Cohort Study of Men Who Have Sex With Men

Objectives. We studied the prevalence and incidence of hepatitis C virus (HCV) infection in the ongoing Omega Cohort Study of men who have sex with men (MSM). Methods. From January to September 2001, consenting men (n = 1085) attending a follow-up visit to the ongoing Omega Cohort Study were tested for HCV. If the test results were positive for HCV, we compared them with test results from previous serum samples collected from the time of entry into the original cohort study to determine the time of infection. Results. HCV prevalence at entry was 2.9% and was strongly associated with injection drug use (32.9% vs 0.3%, P<.0001). Only 1 seroconversion was identified in 2653 person-years of follow-up (incidence rate = 0.038 per 100 person-years). The seroconverter was an active injection drug user who reported needle sharing. Conclusions. Sexual transmission of HCV among MSM appears to be rare

Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto.

Hepatitis B (HBV), hepatitis C (HCV) and other sexually transmitted infections (STIs) have been associated with HIV transmission risk and disease progression among gay men and other men who have sex with men (MSM), but the frequency and distribution of STIs in this community in Canada has not been extensively studied.We recruited MSM living with and without HIV from a large primary care clinic in Toronto. Participants completed a detailed socio-behavioural questionnaire using ACASI and provided blood for syphilis, HIV, HBV and HCV, herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), and human cytomegalovirus (CMV) serology, urine for chlamydia and gonorrhea, and a self-collected anal swab for human papillomavirus (HPV) molecular diagnostics. Prevalences were expressed as a proportion and compared using chi-square.442 MSM were recruited, 294 living with HIV and 148 without. Active syphilis (11.0% vs. 3.4%), ever HBV (49.4% vs. 19.1%), HCV (10.4% vs. 3.4%), HSV-2 (55.9% vs. 38.2%), CMV (98.3% vs. 80.3%) and high-risk (HR) anal HPV (67.6% vs. 51.7%) infections were significantly more common in men living with HIV. Chlamydia and gonorrhea were infrequent in both groups. Regardless of HIV infection status, age and number of lifetime male sexual partners were associated with HBV infection and lifetime injection drug use with HCV infection.Syphilis and viral infections, including HBV, HCV, HSV-2, CMV, and HR-HPV, were common in this clinic-based population of MSM in Toronto and more frequent among MSM living with HIV. This argues for the implementation of routine screening, vaccine-based prevention, and education programs in this high-risk population

Correlates of ever syphilis infection among MSM in Toronto.

<p>Correlates of ever syphilis infection among MSM in Toronto.</p

Prevalence of bacterial and viral pathogens among MSM living with and without HIV in Toronto^*.

<p>Prevalence of bacterial and viral pathogens among MSM living with and without HIV in Toronto^{<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0158090#t002fn001" target="_blank">*</a>}.</p

Correlates of hepatitis B virus infection among MSM in Toronto.

<p>Correlates of hepatitis B virus infection among MSM in Toronto.</p

Demographic characteristics among MSM living with and without HIV in Toronto.

<p>Demographic characteristics among MSM living with and without HIV in Toronto.</p